Stable isotope-labeled tracers for metabolic pathway elucidation by GC-MS and FT-MS.

Advances in analytical methodologies, principally nuclear magnetic resonance spectroscopy (NMR) and mass spectrometry (MS), over the last decade have made large-scale analysis of the human metabolome a reality. This is leading to the reawakening of the importance of metabolism in human diseases, particularly widespread metabolic diseases such as cancer, diabetes, and obesity. Emerging NMR and MS atom-tracking technologies and informatics are poised to revolutionize metabolomics-based research because they deliver the high information throughput (HIT) that is needed for deciphering systems biochemistry. In particular, stable isotope-resolved metabolomics (SIRM) enables unambiguous tracking of individual atoms through compartmentalized metabolic networks in a wide range of experimental systems, including human subjects. MS offers a wide range of instrumental capabilities involving different levels of initial capital outlay and operating costs, ranging from gas-chromatography (GC) MS that is affordable by many individual laboratories to the HIT-supporting Fourier-transform (FT) class of MS that rivals NMR in cost and infrastructure support. This chapter focuses on sample preparation, instrument, and data processing procedures for these two extremes of MS instrumentation used in SIRM.

[1]  Christoph Wittmann,et al.  Respirometric 13C flux analysis--Part II: in vivo flux estimation of lysine-producing Corynebacterium glutamicum. , 2006, Metabolic engineering.

[2]  G. Siuzdak,et al.  Solvent-dependent metabolite distribution, clustering, and protein extraction for serum profiling with mass spectrometry. , 2006, Analytical chemistry.

[3]  A. Lane,et al.  Anaerobic nitrate and ammonium metabolism in flood-tolerant rice coleoptiles , 1997 .

[4]  Gregory Stephanopoulos,et al.  Quantifying Reductive Carboxylation Flux of Glutamine to Lipid in a Brown Adipocyte Cell Line* , 2008, Journal of Biological Chemistry.

[5]  Yu-Shen Cheng,et al.  Qualitative analysis of algal secretions with multiple mass spectrometric platforms. , 2012, Journal of chromatography. A.

[6]  A. Lane,et al.  Stable isotope resolved metabolomics analysis of ribonucleotide and RNA metabolism in human lung cancer cells , 2011, Metabolomics.

[7]  Donald G Robertson,et al.  Metabonomics in toxicology: a review. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.

[8]  V. Go,et al.  Nutrient-gene interaction: tracer-based metabolomics. , 2005, The Journal of nutrition.

[9]  I. Wilson,et al.  Mass spectrometry-based holistic analytical approaches for metabolite profiling in systems biology studies. , 2011, Mass spectrometry reviews.

[10]  George G Harrigan,et al.  Medicinal chemistry, metabolic profiling and drug target discovery: a role for metabolic profiling in reverse pharmacology and chemical genetics. , 2005, Mini reviews in medicinal chemistry.

[11]  Andrew N Lane,et al.  NMR-based stable isotope resolved metabolomics in systems biochemistry , 2011, Journal of biomolecular NMR.

[12]  Andrew N Lane,et al.  Isotopomer-based metabolomic analysis by NMR and mass spectrometry. , 2008, Methods in cell biology.

[13]  Royston Goodacre,et al.  Effective quenching processes for physiologically valid metabolite profiling of suspension cultured Mammalian cells. , 2009, Analytical chemistry.

[14]  J. Rabinowitz,et al.  Acidic acetonitrile for cellular metabolome extraction from Escherichia coli. , 2007, Analytical chemistry.

[15]  Marta Cascante,et al.  Mass isotopomer study of the nonoxidative pathways of the pentose cycle with [1,2-13C2]glucose. , 1998, American journal of physiology. Endocrinology and metabolism.

[16]  L. Boros.  Metabolic targeted therapy of cancer: current tracer technologies and future drug design strategies in the old metabolic network , 2005, Metabolomics.

[17]  Marta Cascante,et al.  K-ras Codon-Specific Mutations Produce Distinctive Metabolic Phenotypes in Human Fibroblasts , 2005 .

[18]  W. Paul Lee,et al.  Tracer-based metabolomics: concepts and practices. , 2010, Clinical biochemistry.

[19]  John T. Wei,et al.  Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression , 2009, Nature.

[20]  Christian M. Metallo,et al.  Elucidation of cellular metabolism via metabolomics and stable-isotope assisted metabolomics. , 2011, Current pharmaceutical biotechnology.

[21]  Andrew N Lane,et al.  The promise of metabolomics in cancer molecular therapeutics. , 2004, Current opinion in molecular therapeutics.

[22]  Joanne M. Morrisey,et al.  Branched Tricarboxylic Acid Metabolism in Plasmodium falciparum , 2010, Nature.

[23]  U. Sauer,et al.  13C-based metabolic flux analysis , 2009, Nature Protocols.

[24]  A. Lane,et al.  Stable isotope-resolved metabolomics and applications for drug development. , 2012, Pharmacology & therapeutics.

[25]  Hunter N. B. Moseley,et al.  Correcting for the effects of natural abundance in stable isotope resolved metabolomics experiments involving ultra-high resolution mass spectrometry , 2010, BMC Bioinformatics.

[26]  T. Fan,et al.  High information throughput analysis of nucleotides and their isotopically enriched isotopologues by direct-infusion FTICR-MS , 2011, Metabolomics.

[27]  Gary Siuzdak,et al.  Phospholipid capture combined with non-linear chromatographic correction for improved serum metabolite profiling , 2006, Metabolomics.

[28]  M. Lerner,et al.  [1,2-13C2]-D-Glucose Profiles of the Serum, Liver, Pancreas, and DMBA-Induced Pancreatic Tumors of Rats , 2005, Pancreas.

[29]  Yuqin Wang,et al.  Targeted metabolomics for biomarker discovery. , 2010, Angewandte Chemie.

[30]  Teresa W.-M. Fan,et al.  Considerations of Sample Preparation for Metabolomics Investigation , 2012 .

[31]  C. Wittmann,et al.  Sampling for metabolome analysis of microorganisms. , 2007, Analytical chemistry.

[32]  David I. Ellis,et al.  Serum metabolomics reveals many novel metabolic markers of heart failure, including pseudouridine and 2-oxoglutarate , 2007, Metabolomics.

[33]  J. Lindon,et al.  Pharmaco-metabonomic phenotyping and personalized drug treatment , 2006, Nature.

[34]  J. Idle,et al.  LC-MS-Based Metabolomics in Drug Metabolism , 2007, Drug metabolism reviews.

[35]  Andrew N. Lane,et al.  Quantification and identification of isotopomer distributions of metabolites in crude cell extracts using 1H TOCSY , 2007, Metabolomics.

[36]  Jun Yao,et al.  Loss of FBP1 by Snail-mediated repression provides metabolic advantages in basal-like breast cancer. , 2013, Cancer cell.

[37]  M. Orešič,et al.  Metabolomic approaches to phenotype characterization and applications to complex diseases , 2006, Expert review of molecular diagnostics.

[38]  A. Lane,et al.  Determination of metabolites by 1H NMR and GC: analysis for organic osmolytes in crude tissue extracts. , 1993, Analytical biochemistry.

[39]  Monica L. Mo,et al.  Global reconstruction of the human metabolic network based on genomic and bibliomic data , 2007, Proceedings of the National Academy of Sciences.

[40]  Royston Goodacre,et al.  Inter-laboratory reproducibility of fast gas chromatography–electron impact–time of flight mass spectrometry (GC–EI–TOF/MS) based plant metabolomics , 2009, Metabolomics.

[41]  Takashi Tsukamoto,et al.  Glucose-independent glutamine metabolism via TCA cycling for proliferation and survival in B cells. , 2012, Cell metabolism.

[42]  J. Nielsen,et al.  Global metabolite analysis of yeast: evaluation of sample preparation methods , 2005, Yeast.

[43]  R. Goodacre,et al.  Global Metabolic Profiling of Escherichia Coli Cultures: an Evaluation of Methods for Quenching and Extraction of Intracellular Metabolites , 2022 .

[44]  K. Dam,et al.  A method for the determination of changes of glycolytic metabolites in yeast on a subsecond time scale using extraction at neutral pH. , 1992 .

[45]  A. Lane,et al.  Stable isotope-resolved metabolomic analysis of lithium effects on glial-neuronal metabolism and interactions , 2010, Metabolomics.

[46]  Götz Schlotterbeck,et al.  Metabolic profiling technologies for biomarker discovery in biomedicine and drug development. , 2006, Pharmacogenomics.

[47]  Andrew N. Lane,et al.  Metabolomics-edited transcriptomics analysis of Se anticancer action in human lung cancer cells , 2006, Metabolomics.

[48]  Wei Liu,et al.  Reprogramming of proline and glutamine metabolism contributes to the proliferative and metabolic responses regulated by oncogenic transcription factor c-MYC , 2012, Proceedings of the National Academy of Sciences.

[49]  John C Lindon,et al.  The comparison of plasma deproteinization methods for the detection of low-molecular-weight metabolites by (1)H nuclear magnetic resonance spectroscopy. , 2002, Analytical biochemistry.

[50]  Oliver Fiehn,et al.  Remodeling of central metabolism in invasive breast cancer compared to normal breast tissue – a GC-TOFMS based metabolomics study , 2012, BMC Genomics.

[51]  Griffin Jl,et al.  Metabonomics: its potential as a tool in toxicology for safety assessment and data integration. , 2004 .

[52]  Andrew N Lane,et al.  A novel deconvolution method for modeling UDP-N-acetyl-D-glucosamine biosynthetic pathways based on 13C mass isotopologue profiles under non-steady-state conditions , 2012, BMC Biology.

[53]  H. Moseley,et al.  Isotopomer analysis of lipid biosynthesis by high resolution mass spectrometry and NMR. , 2009, Analytica chimica acta.

[54]  Andrew N. Lane,et al.  The Handbook of Metabolomics , 2012, Methods in Pharmacology and Toxicology.

[55]  C. Hoppel,et al.  Peroxisomal and Mitochondrial Oxidation of Fatty Acids in the Heart, Assessed from the 13C Labeling of Malonyl-CoA and the Acetyl Moiety of Citrate* , 2005, Journal of Biological Chemistry.

[56]  A. Lane,et al.  Combined use of 1H-NMR and GC-MS for metabolite monitoring and in vivo 1H-NMR assignments. , 1986, Biochimica et biophysica acta.

[57]  Andrew N Lane,et al.  Integrating Metabolomics and Transcriptomics for Probing Se Anticancer Mechanisms , 2006, Drug metabolism reviews.

[58]  M. J. Gradwell,et al.  Analysis of phosphorylated metabolites in crayfish extracts by two-dimensional 1H-31P NMR heteronuclear total correlation spectroscopy (heteroTOCSY). , 1998, Analytical biochemistry.

[59]  T. Stadtman.  Selenium Biochemistry: Mammalian Selenoenzymes , 2000, Annals of the New York Academy of Sciences.

[60]  T. Fan,et al.  A carbonyl capture approach for profiling oxidized metabolites in cell extracts , 2012, Metabolomics.

[61]  O. Fiehn,et al.  Metabolite profiling for plant functional genomics , 2000, Nature Biotechnology.

[62]  A. Lane,et al.  Stable isotope resolved metabolomics of lung cancer in a SCID mouse model , 2011, Metabolomics.

[63]  T. Fan,et al.  The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type. , 2012, Cell metabolism.

[64]  T. Fan,et al.  Altered regulation of metabolic pathways in human lung cancer discerned by 13C stable isotope-resolved metabolomics (SIRM) , 2009, Molecular Cancer.

[65]  R. Takors,et al.  Metabolomics: quantification of intracellular metabolite dynamics. , 2002, Biomolecular engineering.

[66]  Hunter N.B. Moseley,et al.  Error Analysis and Propagation in Metabolomics Data Analysis , 2013, Computational and structural biotechnology journal.